Table 2 |
|||
|
Changes in plasma levels of homocysteine, cysteine, and cysteinylglycine from baseline to week 12 in overweight men who consumed a CRD. |
|||
| Parameter |
Baseline |
Week 12 |
P Value (Time) |
|
|
|||
| Homocysteine (μmol/L) |
|||
| Fiber |
8.1 ± 1.2 |
8.6 ± 2.2 |
> 0.05 |
| Placebo |
8.1 ± 1.4 |
8.3 ± 1.5 |
> 0.05 |
| Cysteine (μmol/L) |
|||
| Fiber |
264.4 ± 34.1 |
258.9 ± 45.3 |
> 0.05 |
| Placebo |
269.0 ± 30.5 |
266.2 ± 40.7 |
> 0.05 |
| Cysteinylglycine (μmol/L) |
|||
| Fiber |
30.3 ± 5.1 |
29.9 ± 4.5 |
> 0.05 |
| Placebo |
30.9 ± 3.8 |
29.0 ± 5.5 |
> 0.05 |
|
|
|||
|
Data are presented as means ± SD for the fiber group (n = 14) and the placebo group (n = 14). P values refer to the difference between baseline and week 12. No significant time or treatment effects were observed in any measured plasma marker of homocysteine metabolism. Subjects supplemented the CRD by consuming a standard multivitamin every-other day. |
|||
|
Wood et al. Nutrition & Metabolism 2006 3:19 doi:10.1186/1743-7075-3-19 |
|||
